More and more genetic variants of diabetes such as MODY are being recognised all the time, and these are extremely important, because they open up new possibilities for early diagnosis and treatment. In particular, these advances make it clear that diabetes can no longer simply be divided into Type 1 and Type 2, and that we need to address treatment of the individual patient rather than attempt to force people into diagnostic pidgeonholes that they may not really fit.

TW